KYMR
#919
Kymera Therapeutics, Inc. - Common Stock
117.7 7 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.88%
Variación mensual
+14.60%
Variación en los últimos 6 meses
+31.97%
Cambio anual
+99.27%
Cierres anteriores
118.8 1
Open
118.2 3
Mínimo
117.7 7
Máximo
118.3 9
Volumen
104
Financials
- Market Capitalization 9.79 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-35.28
Relación precio/flujo de caja
106.17
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 907 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.51 USD | -0.15% | -1.78% | +6.25% | +98.03% | 9.99 B USD | ||
| 908 |  CYTK Cytokinetics, Incorporated - Common Stock | 71.78 USD | +1.23% | -8.26% | -6.40% | +23.55% | 9.98 B USD | ||
| 920 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 350.58 USD | +0.08% | -4.16% | +16.50% | +677.34% | 9.79 B USD | ||
| 938 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 146.69 USD | -0.72% | -3.90% | +8.02% | +95.25% | 9.49 B USD |